跳至主要内容
临床试验/ISRCTN96851026
ISRCTN96851026进行中(未招募)Unknown

A prospective, multi-center, observational, non-comparative, postmarketing surveillance study to obtain clinical outcome data on the Nagor PERLE™ range of silicone breast implants when used in breast augmentation or reconstruction for women from 18 to 65 years

agor Ltd0 个研究点目标入组 700 人开始时间: 2023年9月8日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
Female

入选标准

  • 1. Genetic female subjects aged =18 and =65 years
  • 2. Subjects who underwent single or bilateral breast implantation with the study device for one of the following reasons:
  • 2.1. Primary breast reconstruction following mastectomy (both for one-stage or two-stage surgeries, including patients with previous radiotherapy and who have ADMs of animal origin (bovine, porcine)).
  • 2.2. Primary breast augmentation (cosmetic surgery) with or without mastopexy
  • 2.3. Breast revision surgery with or without mastopexy
  • 3. Subjects who have received a Nagor PERLE implant.
  • 4. Subjects who have provided informed consent and can adhere to the requirements of follow-up appointments as per the study protocol.

排除标准

  • 1. Subjects undergoing implant augmentation with a BMI > 30 and undergoing reconstruction with a BMI >32
  • 2. Subjects with autoimmune disease, lung fibrocystic disease, conditions that interfere with wound healing and blood clotting, a weakened immune system, reduced blood supply to the breast tissue or any other condition for which breast implants are contraindicated.
  • 3. Subjects who have participated in a clinical study which involves chemical or drug study within 3 months prior to surgery, with the exception of subjects who are participating in breast cancer related clinical studies
  • 4. Subjects with insufficient tissue covering due to either radiation damage on the chest wall, tight thoracic skin grafts or radical resection of the pectoralis major muscle
  • 5. Subjects who have ADMs of synthetic origin
  • 6. Subjects who, in the Investigator’s clinical opinion, have existing local or metastatic carcinoma of the breast that is unlikely to be fully excised at the time of insertion of the breast implant
  • 7. Subjects with a known previous history of a sensitivity to silicone who, in the opinion of the Investigator, are unsuitable for surgery
  • 8. Subjects with an active infection who are unsuitable for surgery unless, in the opinion of the investigator, they are treated and cleared by the investigator
  • 9. Subjects with a history of abscesses anywhere in the body who, in the opinion of the Investigator, are unsuitable for surgery
  • 10. Subjects with a known history of compromised wound healing
  • 11. Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study
  • 12. Women who are pregnant and/or current breastfeeders who do not stop breastfeeding within 3 months of getting breast implants
  • 13. Patients who have local recurrence or metastatic carcinoma at the time of insertion of breast implant

研究者

发起方
agor Ltd

相似试验